We then expressed AR-V7 in an immunocompetent murine colorectal line known to respond to antigen-specific vaccination and demonstrated that adenoviral AR-V7 vaccination suppressed tumor growth and improved survival in both preventative and therapeutic vaccination strategies. This evidence concerns the gene AR and neoplasm.